clinical trial · NCT05470075
A Study to Evaluate the Efficacy and Safety of HR18042 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery.
Jiangsu HengRui Medicine Co., Ltd.·phase2·terminated·n = 110
PainHR18042 tabletsHR18042 tabletsHR18042 tabletsTramadol hydrochloride SR TabletsPlacebos
brief summary
This is a multicenter, randomized, double-blind, dose finding, parallel controlled with active drug and placebo, phase II clinical trial, and the purpose of the study is to evaluate the efficacy and safety of HR18042 tablets for postoperative analgesia after impacted teeth removal surgery.
started
Aug 11, 2022
primary completion
Dec 16, 2022
completion
Dec 16, 2022
last updated
Jun 26, 2025
official title
A Multicenter, Randomized, Double-blind, Dose Finding, Parallel Controlled With Active Drug and Placebo, Phase II Clinical Trial to Evaluate the Efficacy and Safety of HR18042 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol